Diaceutics (GB:DXRX)
LSE:DXRX

Diaceutics (DXRX) Technical Analysis

7 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Diaceutics’s (DXRX) Moving Averages Convergence Divergence (MACD) indicator is 2.41, suggesting Diaceutics is a Buy.
Diaceutics’s (DXRX) 20-Day exponential moving average is 129.96, while Diaceutics’s (DXRX) share price is 131p, making it a Buy.
Diaceutics’s (DXRX) 50-Day exponential moving average is 124.48, while Diaceutics’s (DXRX) share price is 131p, making it a Buy.

Diaceutics (DXRX) Pivot Points

Jul 25, 2024, 11:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
122.87
126.49
128.75
132.37
134.63
138.25
140.51
Fibonacci
126.49
128.74
130.13
132.37
134.62
136.01
138.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Diaceutics (DXRX) Moving Averages

Jul 25, 2024, 11:57 PM
Period
Simple
Exponential
MA5
132.60Sell
131.94Sell
MA10
132.15Sell
131.61Sell
MA20
129.93Buy
129.96Buy
MA50
126.59Buy
124.48Buy
MA100
114.11Buy
117.11Buy
MA200
102.95Buy
109.05Buy
Diaceutics’s (DXRX) 10-Day exponential moving average is 131.61, while Diaceutics’s (DXRX) share price is 131p, making it a Sell.
Diaceutics’s (DXRX) 100-Day exponential moving average is 117.11, while Diaceutics’s (DXRX) share price is 131p, making it a Buy.
Diaceutics’s (DXRX) stock price is 131p and Diaceutics’s (DXRX) 50-day simple moving average is 126.59, creating a Buy signal.
Diaceutics’s (DXRX) stock price is 131p and Diaceutics’s (DXRX) 100-day simple moving average is 114.11, creating a Buy signal.
Diaceutics’s (DXRX) stock price is 131p and Diaceutics’s (DXRX) 200-day simple moving average is 102.95, creating a Buy signal.

Diaceutics (DXRX) Technical Indicators

Jul 25, 2024, 11:57 PM
Name
Value
Implied Action
RSI (14)
57.46
Neutral
STOCH (9,6)
40.28
Neutral
STOCHRSI (14)
63.00
Neutral
MACD (12,26)
2.41
Buy
ADX (14)
23.48
Neutral
Williams %R
-55.56
Buy
CCI (14)
26.68
Neutral
ATR (14)
2.91
-
Ultimate Oscillator
49.62
Neutral
ROC
3.97
Buy
Diaceutics’s (DXRX) Relative Strength Index (RSI) is 57.46, creating a Neutral signal.
Diaceutics’s (DXRX) Trend Strength Indicator (ADX) is 23.48, creating a Neutral signal.
Diaceutics’s (DXRX) Commodity Channel Index (CCI) is 26.68, creating a Neutral signal.
Diaceutics’s (DXRX) Price Rate of Change (ROC) is 3.97, creating a Buy signal.

FAQ

Is DXRX a Buy, Hold, or Sell?
Based on DXRX’s technical indicators, DXRX is a Buy.
    What is DXRX’s RSI (14)?
    DXRX’s RSI (14) is 57.46, which suggests DXRX is a Neutral.
      What is DXRX’s MACD?
      DXRX’s MACD is 2.41, which suggests DXRX is a Buy.
        What is DXRX’s 5-day moving average?
        DXRX’s 5-day moving average is 132.60, which suggests DXRX is a Sell.
          What is DXRX’s 20-day moving average?
          DXRX 20-day moving average is 129.93, which suggests DXRX is a Buy.
            What is DXRX’s 50-day moving average?
            DXRX’s 50-day moving average is 126.59, which suggests DXRX is a Buy.
              What is DXRX’s 200-day moving average?
              DXRX’s 200-day moving average is 102.95, which suggests DXRX is a Buy.
                What is DXRX’s Williams % R (14)?
                DXRX’s Williams % R (14) is -55.56, which suggests DXRX is a Buy.
                  What is DXRX’s CCI (14)?
                  DXRX’s CCI (14) is 26.68, which suggests DXRX is a Neutral.
                    What is the share price of Diaceutics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis